CLINICAL LAB SCIENEC

INDEX 469
Immigration, diseases and, 2
Immune reaction, principle,
401–402
Immunization(s)
in bloodborne- and airborne
pathogen–related infection
prevention, 150–151
in bloodborne- or airborne
pathogen–related infection
prevention, in medical laboratory
workers, 147–148
in infection control, 129–132
MMR, 150–151
Immunocompromised hosts, 388
Immunohematology (blood banking),
81–82, 415–431
accuracy in, 419
blood typing for Rh factor, slide
and tube method, 428–430,
429f
equipment and supplies,
428–429
principles, 428
procedures, 429–430, 429f
reporting of results, 430
direct blood grouping by test tube
method, 422–424
equipment and supplies, 423
principles, 422–423
procedure, 423–424
reporting of results, 424
direct blood or forward grouping
by slide method, 424–426,
425f
equipment and supplies, 425
principles, 424, 425f
procedure, 425–426
reporting of results, 426
indirect (reverse) grouping by
tube, 426–427, 427f
equipment and supplies, 426
principles, 426
procedure, 427, 427f
reporting of results, 427–428
introduction to, 415–416
safety in, 419
therapeutic use of, 416–419, 418f,
418t
2% to 5% cell suspension preparations,
419–422
equipment and supplies, 420
principle, 419–420
procedure, 420–421
reporting of results, 422
Immunology, 83, 401–413
C-reactive protein in serum determination,
407–410
described, 402
introduction to, 401–403
methodologies, 403–404
quantitative procedures, 403
semiquantitative procedures, 403
serial dilution procedure, 404–
407, 405f, 406f
Incinerator(s), bacterial, 388, 389f
Indirect grouping, by tube, 426–427,
427f. See also Immunohematology
(blood banking),
indirect (reverse) grouping
by tube
Indirect pay, 159
Infection(s). See also specific types
causes of, 388
defined, 112
fungal, 388, 389
iatrogenic, 119
nosocomial, 119
prevention of
exposure training and immunization
in, 129–132
HIV effects on, 113–115, 115t
types of, 388, 389f
Infection control
in allied health students, 121–124,
122f, 123f
as barrier against contamination,
122f–125f, 124–126
bloodborne and airborne pathogens
and, 147–152, 149f.
See also Airborne pathogens;
Bloodborne pathogens
defined, 112
disposal and decontamination in,
153
documentation of exposure incident
in, 132–134
exposure potential and prevention
in, 126–129, 129f, 152–153
exposure training and immunization
in, 129–132, 152–153
HBV, 130–131
HIV, 130
immediate action after possible
exposure, 131–132
postexposure treatment for exposure
to blood or OPIM, 132
preexposure records, 129
storage and maintenance of,
131
in faculty members, 121–124,
122f, 123f
hazard communication in, 117
HBV, limiting spread of, 130–131,
136–139, 137f, 138f
health care facilities and, relationship
between, 115–116
history of, 113
HIV, limiting spread of, 130,
134–136
infectious exposure guidelines in,
152–153
introduction to, 111–154
measures in, 5
in medical care workers, 121–124,
122f, 123f
modern-day, 113–117, 115t
policies related to, official agencies
responsible for, 116–117
safety checklist for, 99–100, 99t
TB, 139–146, 141f, 142f, 146t.
See also Tuberculosis (TB)
during venipuncture, 267t
Infection Control Committee,
85–86, 85t, 91, 92, 99, 116,
119, 129, 152
Informed consent, patient’s rights
for, basics of, 66, 68
Injury(ies), defined, 103
INR (International Normalized
Ratio), 329, 361
Instructor(s), in educational facilities,
safety responsibilities of,
101–102
Insurance
health care, 158–163. See also
Health care providers and
insurance
reimbursement and, 159–160
Intellectual requirements, for
medical laboratory workers,
13–14
International Normalized Ratio
(INR), 329, 361
Copyright 2010 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. Due to electronic rights, some third party content may be suppressed from the eBook and/or eChapter(s).
Editorial review has deemed that any suppressed content does not materially affect the overall learning experience. Cengage Learning reserves the right to remove additional content at any time if subsequent rights restrictions require it.